Two Organisations are Collaborating Over a Potential Drug for Progressive Supranuclear Palsy
rawpixel / Pixabay

Two Organisations are Collaborating Over a Potential Drug for Progressive Supranuclear Palsy

The Parkinson’s Institute and Clinical Center and Retrotope are teaming up to study a potential new therapy for patients with progressive supranuclear palsy. For more information about this collaboration, you…

Continue Reading Two Organisations are Collaborating Over a Potential Drug for Progressive Supranuclear Palsy
Experimental Treatment for WHIM Syndrome Gets Orphan Drug Designation
jarmoluk / Pixabay

Experimental Treatment for WHIM Syndrome Gets Orphan Drug Designation

According to a story from BioSpace, the biotechnology company X4 Pharmaceuticals recently announced that the US Food and Drug Administration (FDA) has given Orphan Drug designation to the company's investigational…

Continue Reading Experimental Treatment for WHIM Syndrome Gets Orphan Drug Designation
Insights into Cancer Research from Dr Crystal Mackall, Founding Director of the Stanford Center for Cancer Cell Therapy
ar130405 / Pixabay

Insights into Cancer Research from Dr Crystal Mackall, Founding Director of the Stanford Center for Cancer Cell Therapy

A recent discussion between Dr Crystal Mackall and Dr Lynn Zydowsky explored the research, challenges, and future of cancer gene therapies. Dr Mackall is a doctor and renowned cancer researcher…

Continue Reading Insights into Cancer Research from Dr Crystal Mackall, Founding Director of the Stanford Center for Cancer Cell Therapy
Program Aims to Help Diagnose Certain Rare Diseases More Quickly
Free-Photos / Pixabay

Program Aims to Help Diagnose Certain Rare Diseases More Quickly

According to a story from PR Newswire, a new program called The Lantern Project is working to provide a free testing program that allow doctors to more quickly diagnose patients…

Continue Reading Program Aims to Help Diagnose Certain Rare Diseases More Quickly
A Biomarker, an App, and Real-World Data: How Biogen is Trying to Improve Treatment for Patients With Multiple Sclerosis
Bru-nO / Pixabay

A Biomarker, an App, and Real-World Data: How Biogen is Trying to Improve Treatment for Patients With Multiple Sclerosis

As part of their work to support the treatment of patients with multiple sclerosis, Biogen has been investigating a potential new biomarker for the disease called serum neurofilament light (sNfL),…

Continue Reading A Biomarker, an App, and Real-World Data: How Biogen is Trying to Improve Treatment for Patients With Multiple Sclerosis

A Gene Therapy for Sickle Cell Disease has Been Approved for an Investigational New Drug Application by the FDA

The United States Food and Drug Administration has accepted an Investigational New Drug application (IND) for an investigational gene therapy designed to be a treatment for sickle cell disease. Previously,…

Continue Reading A Gene Therapy for Sickle Cell Disease has Been Approved for an Investigational New Drug Application by the FDA